Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Capreomycin (750mg) Injection
Therapeutic Category
Antibacterials, Antibiotic
Dosage Form
Injection
Packaging Type
Vial
Packaging
750mg
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Some patients may experience injection site pain, dizziness, nausea, kidney function disturbances, hearing impairment, or electrolyte imbalance. Rarely, severe allergic reactions or significant ototoxicity and nephrotoxicity may occur and require immediate medical attention.
Capofen 750 Injection is indicated for multidrug-resistant tuberculosis (MDR-TB) and other resistant mycobacterial infections as part of combination antitubercular therapy. It helps reduce bacterial load and supports long-term infection control.
This injection should be administered strictly under medical supervision by qualified healthcare professionals. Regular monitoring of kidney function, hearing, and electrolyte levels is recommended during treatment. Use only as part of an appropriate combination antitubercular regimen.
Store below 25°C, protected from moisture and direct sunlight. Keep the vial in its original packaging and out of reach of children.
Composition : Cefepime (1000mg) Injection
Composition : Cefepime (1000mg) + Tazobactum (125mg)
Composition : Cefepime (250mg)
Composition : Cefoperazone (1000mg) + Sulbactam (500mg)
Composition : Cefoperazone (500mg) + Sulbactam (500mg)
Composition : Ceftazidime (1gm)
Composition : Ceftazidime (250mg)
Composition : Ceftriaxone (1000mg) + Sulbactam (500mg)
Composition : Ceftriaxone (125mg) Injection
Composition : Ceftriaxone (250mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Capreomycin 750mg Injection has specialized and high-value demand in the hospital, pulmonology, infectious disease, and anti-tubercular segment, making it a niche product for medical distributors, wholesalers, and pharma franchise partners focusing on critical-care and TB treatment portfolios.
Medical distributors and agencies can benefit from institutional demand for resistant tuberculosis treatment under strict medical supervision. Capreomycin 750mg is a second-line injectable anti-tubercular antibiotic Commonly used in the management of multi-drug resistant tuberculosis (MDR-TB) and complicated tuberculosis cases as part of combination therapy Plays a significant role in specialized TB treatment protocols when first-line anti-TB medicines are ineffective or inappropriate Widely utilized in TB specialty clinics, pulmonology departments, infectious disease units, and tertiary care hospitals Requires administration and monitoring by qualified healthcare professionals This strengthens a specialized anti-tubercular and infectious disease portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Capreomycin 750mg Injection with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from institutional procurement opportunities, specialist-driven demand, niche therapeutic positioning, and relatively lower market competition, along with reliable supply chain support and strong margin potential in the anti-tubercular segment.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from professional marketing support, quality pharmaceutical products, and a dependable supply chain for sustainable business growth.